Stallergenes Greer

Stallergenes Greer company information, Employees & Contact Information

Stallergenes Greer is a global biopharmaceutical company specialising in allergy therapeutics through the research, development and commercialisation of allergen immunotherapy products and services. Supported by more than 100 years of expertise and innovation, our products are available for patients in over 40 countries. Our purpose is to enable precision medicine to improve life for people with allergies. With more than 1,100 employees worldwide and manufacturing facilities in both Europe and the United States, Stallergenes Greer is driving a continuing leadership in allergy immunotherapy. Link to our privacy policy: https://www.stallergenesgreer.com/personal-data-protection-policy

Company Details

Employees
1.12K
Founded
-
Address
Zugerstrasse 76b, Baar,switzerland 6340,switzerland
Phone
+44-20-72394500
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Baar, Switzerland
Looking for a particular Stallergenes Greer employee's phone or email?

Stallergenes Greer Questions

News

Q&A on Palforzia® Peanut OIT: Early Intervention in Toddlers - Allergic Living

Q&A on Palforzia® Peanut OIT: Early Intervention in Toddlers Allergic Living

Stallergenes Greer Announces Palforzia® Featured on "The Balancing Act" Airing on Lifetime TV - Yahoo Finance

Stallergenes Greer Announces Palforzia® Featured on "The Balancing Act" Airing on Lifetime TV Yahoo Finance

Stallergenes Greer Announces Appointment of Andreas Amrein as Chief Executive Officer - Business Wire

Stallergenes Greer Announces Appointment of Andreas Amrein as Chief Executive Officer Business Wire

Transition of Promotional Activities for Allergen Immunotherapy Drug Actair® in Japan - The AI Journal

Transition of Promotional Activities for Allergen Immunotherapy Drug Actair® in Japan The AI Journal

Stallergenes Greer Showcases Developments in Respiratory and Food Allergy Care at EAACI 2025 - Business Wire

Stallergenes Greer Showcases Developments in Respiratory and Food Allergy Care at EAACI 2025 Business Wire

Stallergenes Greer and Nuance Pharma Enter Exclusive Long-term Partnership for Actair - Business Wire

Stallergenes Greer and Nuance Pharma Enter Exclusive Long-term Partnership for Actair Business Wire

Science Awards for Allergy 2025: Call for Applications - STT Info

Science Awards for Allergy 2025: Call for Applications STT Info

Allergen Immunotherapy for the Prevention and Treatment of Asthma - Batard - 2025 - Clinical & Experimental Allergy - Wiley Online Library

Allergen Immunotherapy for the Prevention and Treatment of Asthma - Batard - 2025 - Clinical & Experimental Allergy Wiley Online Library

FDA approves peanut oral immunotherapy for toddlers - Healio

FDA approves peanut oral immunotherapy for toddlers Healio

Oralair Approved for Younger Patients With Grass Pollen Allergy - Medical Professionals Reference

Oralair Approved for Younger Patients With Grass Pollen Allergy Medical Professionals Reference

Oral Immunotherapy for the Treatment of Peanut Allergy Now Available in the U.S. for Pediatric Ages 1 Through 3 Years - Business Wire

Oral Immunotherapy for the Treatment of Peanut Allergy Now Available in the U.S. for Pediatric Ages 1 Through 3 Years Business Wire

TH2A cell frequencies following immunotherapy with house dust mite tablet correlates with humoral responses - Wiley Online Library

TH2A cell frequencies following immunotherapy with house dust mite tablet correlates with humoral responses Wiley Online Library

European Commission Approves the Extension of the Indication of Palforzia® to the Treatment of Toddlers With Confirmed Peanut Allergy - Business Wire

European Commission Approves the Extension of the Indication of Palforzia® to the Treatment of Toddlers With Confirmed Peanut Allergy Business Wire

FDA Approves U.S. Pediatric Indication Extension for Palforzia - Business Wire

FDA Approves U.S. Pediatric Indication Extension for Palforzia Business Wire

Stallergenes Greer Announces Global Agreement With Nestlé Regarding the Peanut Allergy Oral Immunotherapy Treatment Palforzia® - Business Wire

Stallergenes Greer Announces Global Agreement With Nestlé Regarding the Peanut Allergy Oral Immunotherapy Treatment Palforzia® Business Wire

Aptar Digital Health Reports Positive Impact of iPUMP® on Sublingual Liquid Allergen Immunotherapy Adherence - Business Wire

Aptar Digital Health Reports Positive Impact of iPUMP® on Sublingual Liquid Allergen Immunotherapy Adherence Business Wire

Positive Outcome of European Decentralised Registration Procedure for Stallergenes Greer’s Sublingual House Dust Mite Allergen Immunotherapy Tablet - Business Wire

Positive Outcome of European Decentralised Registration Procedure for Stallergenes Greer’s Sublingual House Dust Mite Allergen Immunotherapy Tablet Business Wire

Top Stallergenes Greer Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant